The regulatory and legal landscape surrounding the L-Carnitine Orotate market is influenced by several factors, particularly in the pharmaceutical sector
The medication makes it difficult to distinguish between eating disorder behaviors and medication effectsa dangerous blurring of lines
Marketing Authorization Holder GERDA LABORATORIES 24 RUE ERLANGER 75016 PARIS Operator of the marketing authorization GERDA LABORATORIES 24 RUE ERLANGER 75016 PARIS Maker DELPHARM TOURS LA BARAUDIERE 37170 CHAMBRAY LES TOURS or HAUPT PHARMA LIVRON 1 STREET COUNTY SINARD 26250 LIVRON-SUR-DROME Names of the drug in the member states of the European Economic Area Not applicable
Morris MC, Schneider JA, Li H, Tangney CC, Nag S, Bennett DA et al
If the patient is unable to hold the GLP-1 receptor agonist for at least 3 half-lives before the procedure, consider rapid-sequence induction of general anesthesia, to reduce the risk of aspiration, and consider the use of point-of-care gastric ultrasonography, where available, to check for residual gastric content